Issue 4

Legalized Cannabis, The State of Pharma & Job Losses

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Is Cannabis Legislation a Promising Sign for Pharmaceutical Cannabinoids?

Whilst Amsterdam has long been considered the global home of cannabis use, Western countries are slowly changing their stance on its use. In 2012, U.S. states Colorado and Washington both legalized recreational cannabis, with many other states since following. Other countries have legalized cannabis too - including Canada, Mexico and South Africa - and although still illegal in many other countries, it is often decriminalized or not enforced as a crime.

Read more here.

FEATURED STORIES

IQVIA Global Trends in R&D 2024 Report

Read more here.

KPMG Releases Life Sciences CEO Outlook Report

Read more here.

2024 Pharma Job Loss Announcements

Read more here.

FDA to Waive Drug Registration Fees for Smaller Companies

Read more here.

Zealand Pharma Announces Obesity Success with Liver Disease Treatment

Read more here.

Viking Therapeutics' Obesity Drug Exceeds Competitors

Read more here.

Abbvie Announces New CEO, Bond Sell Off & OSE Immunotherapeutics Deal

Read more here.

Redx Pharma Clinical Trial for Pioneering Crohn's Disease Medication

Read more here.

AstraZeneca’s Tagrisso Receives Chemotherapy FDA Approval

Read more here.

Janus Therapeutics Value Increases Upon Trial Results

Read more here.

GSK Demonstrates Advanced-Phase Gonorrhea Success

Read more here.

Novo Nordisk Enters $1.46 Billion Agreement for Molecular Glue Treatments Development

Read more here.

Zeno Health Obtains $25 Million in Series C investment

Read more here

Curve Therapeutics Secures Over $50 Million to Accelerate Its Discovery Platform

Read more here.